Compumedics Limited (AU:CMP) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Compumedics Limited has reported a banner year with record sales orders of approximately $52 million, up 22%, and revenues of $49 million, a 16% increase from the previous year. The growth was driven by strong performance in Australian sleep and neurodiagnostic businesses, new MEG orders in China, and significant sales growth in the US market. Compumedics’ SaaS revenues from Somfit and Nexus 360 also saw a substantial jump to $4.2 million, indicating a promising outlook for the medical device company.
For further insights into AU:CMP stock, check out TipRanks’ Stock Analysis page.